In early 2023, Invistics, part of Wolters Kluwer, collaborated with Eliciting Insights to conduct a study to assess healthcare executives’ perceptions of drug diversion programs. Surveys were administered to healthcare executives in four critical areas: pharmacy, nursing, administrative/medical, and drug diversion specialists.

To learn more, download the report here or read the full press release.